论文信息 - Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies - 字舞流文

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

L. Voltolini | N. Sobhani | A. D’Angelo | S. Bagby | G. Roviello | K. Ferrari | R. Chapman | M. Traversini | Carlotta Bortoletti | Jacob Darlow